Cuprizone-driven demyelination impacts sleep architecture in rodents, study shows
March 11, 2024
Patients with multiple sclerosis have an increased prevalence of sleep disorders compared to the general population, with an estimated rate ranging from 25% to 50% and negative impacts on quality of life.